licensing

Open Innovation between established and emerging bio-pharmaceuticals

By rnd-admin
on 3 March, 2021

In the UK, early stage bio-pharmaceutical companies gain enhanced patenting performance through Open Innovation in contrast to the established companies, which experienced challenges. This is one for the findings by Despoina Filiou and is contrary to the experience in...

Valuing and comparing small portfolios

Many of the tools used in valuing and selecting projects are only really applicable...
Improving Product Features: When is More Less?

Different types of feature have different effects on customer satisfaction - analysis by Quality...
Failure Mode and Effects Analysis (FMEA)

To fail fast can save enormous waste later in the product lifecycle. Failure Mode...
Using the game 'Top Trumps' as a communications tool

Large R&D centric businesses have a huge asset in the vast experience that exists...
The Halo-Effect: Creating Impact Through “Good-looking“ Roadmaps

Content is the essence of roadmapping. But the impact of impressive, professional visuals that...